Lucentis
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Lucentis |
|---|---|
| Active Substance | ranibizumab |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| ATC Code | S01LA04 |
| Medicinal product marketed in the Croatia | Nestašica |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
| Educational materials for patients / caregivers |
Vodič za bolesnike - dijabetička retinopatija ili dijabetički makularni edem, verzija 1 Vodič za bolesnike neovaskularizacia žilnice, verzija 4 Vodič za bolesnike neovaskularna senilna makularna degeneracija, verzija 4 Vodič za bolesnike začepljenje vene u pozadini mrežnice, verzija 4 Vodiče za bolesnike dijabetički makularni edem, verzija 4 |
